Receptor for AGE (RAGE) Mediates Neointimal Formation in Response to Arterial Injury

Author:

Zhou Zhongmin1,Wang Kai1,Penn Marc S.1,Marso Steven P.1,Lauer Michael A.1,Forudi Farhad1,Zhou Xiaorong1,Qu Wu1,Lu Yan1,Stern David M.1,Schmidt Ann Marie1,Lincoff A. Michael1,Topol Eric J.1

Affiliation:

1. From the Experimental Interventional Laboratory, Department of Cardiovascular Medicine (Z.Z., K.W., M.S.P., F.F., X.Z., A.M.L., E.J.T.), Cleveland Clinic Foundation, Cleveland, Ohio; Mid American Heart Institute (S.P.M.), Saint Luke’s Hospital, Kansas City, Mo; Borgess Hospital Research Institute (M.A.L.), Kalamazoo, Mich; and Columbia University (W.Q., Y.L., A.M.S., D.M.S.), College of Physician and Surgeons, New York, NY.

Abstract

Background— Receptor for advanced-glycation end products (RAGE) and its ligands AGEs and S100/calgranulins have been implicated in a range of disorders. However, the role of RAGE/ligand interaction in neointimal hyperplasia after vascular injury remains unclear. Methods and Results— We examined the expression of RAGE and its ligands after balloon injury of the carotid artery in both Zucker diabetic and nondiabetic rats. Using a soluble portion of the extracellular domain of RAGE, we determined the effects of suppressing RAGE/ligand interaction on vascular smooth muscle cell (VSMC) proliferation and neointimal formation after arterial injury. We demonstrate a significantly increased accumulation of AGE and immunoreactivities of RAGE and S100/calgranulins in response to balloon injury in diabetic compared with nondiabetic rats. Blockade of RAGE/ligand interaction significantly decreased S100-stimulated VSMC proliferation in vitro and bromodeoxyuridine (BrdU)–labeled proliferating VSMC in vivo, and suppressed neointimal formation and increased luminal area in both Zucker diabetic and nondiabetic rats. Conclusions— These findings indicate that RAGE/ligand interaction plays a key role in neointimal formation after vascular injury irrespective of diabetes status and suggest a novel target to minimize neointimal hyperplasia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3